James Hardie (JHX) jumps as FY27 outlook highlights EBITDA and free-cash-flow step-up

James Hardie Industries plc (JHX) is up 7.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move higher appears tied to James Hardie’s Q4 FY26 / full-year FY26 results and its FY27 outlook, which emphasized adjusted EBITDA beating expectations in the quarter and a sizable step-up in FY27 free cash flow. Investors may be focusing on synergy progress from the AZEK combination and management’s expectation for earnings growth even without assuming a housing-market recovery.

Details:

Q4 FY26 net sales were $1.40 billion (up 45% year over year) while organic net sales fell 1%; adjusted EBITDA was $381 million and described as above the company’s guidance range.

For FY27, the company targeted total net sales of $5.25–$5.41 billion and total adjusted EBITDA of $1.45–$1.50 billion, alongside a free-cash-flow target of at least $500 million (more than $200 million above FY26).

FY26 net sales were $4.84 billion (up 25% year over year) and FY26 adjusted EBITDA was $1.27 billion (up 17%); management also highlighted cost synergies ahead of schedule and commercial synergies on track.

Offsetting factors include much higher leverage following the AZEK acquisition and a large gap between GAAP earnings and non-GAAP profitability due to acquisition-related, restructuring, and other items.

Sources:

James Hardie Investor Relations, SEC (Form 8-K), The Motley Fool

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$JHX Hedge Fund Activity

We have seen 144 institutional investors add shares of $JHX stock to their portfolio, and 192 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 20,166,220 shares (+181.9%) to their portfolio in Q1 2026, for an estimated $381,948,206
D1 CAPITAL PARTNERS L.P. added 3,897,570 shares (+16.0%) to their portfolio in Q1 2026, for an estimated $73,819,975
CITADEL ADVISORS LLC removed 2,659,683 shares (-35.0%) from their portfolio in Q1 2026, for an estimated $50,374,396
ALYESKA INVESTMENT GROUP, L.P. added 2,617,473 shares (+50.7%) to their portfolio in Q1 2026, for an estimated $49,574,938
BARCLAYS PLC added 2,556,886 shares (+807.3%) to their portfolio in Q1 2026, for an estimated $48,427,420
SCHONFELD STRATEGIC ADVISORS LLC added 2,346,396 shares (+229.3%) to their portfolio in Q1 2026, for an estimated $44,440,740
HOLOCENE ADVISORS, LP added 2,223,898 shares (+2251.0%) to their portfolio in Q1 2026, for an estimated $42,120,628

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$JHX Price Targets

Multiple analysts have issued price targets for $JHX recently. We have seen 2 analysts offer price targets for $JHX in the last 6 months, with a median target of $26.0.

Here are some recent targets:

Matthew Bouley from Barclays set a target price of $22.0 on 04/08/2026
Keith Hughes from Truist Securities set a target price of $30.0 on 02/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.